Vir Biotechnology, Inc.

Historical 13F Holders

Symbol
VIR
CUSIP
92764N102
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92764N102 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 12.4% 10/27/2026
Event 9/30/2026
ARCH Venture Fund IX, L.P. 13D/A
7.3% 11/6/2026
Event 11/4/2026
Vanguard Portfolio Management LLC 13G/A 6.9% 7/31/2026
Event 6/30/2026
SB Investment Advisers (UK) Ltd 13G/A
6.5% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
State Street Corp 13G 4.6% 11/10/2026
Event 9/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 268 140 M $1.57B
2026 Q2 240 147 M $1.49B
2026 Q1 256 140 M $1.26B
2025 Q4 221 116 M $698M
2025 Q3 214 107 M $611M
2025 Q2 216 111 M $558M
2025 Q1 238 93.3 M $604M
2024 Q4 211 88.8 M $652M
2024 Q3 199 87.6 M $656M
2024 Q2 218 88.1 M $784M
2024 Q1 213 88.9 M $901M
2023 Q4 208 88.2 M $887M
2023 Q3 215 88.3 M $827M
2023 Q2 230 90.8 M $2.23B
2023 Q1 236 88.8 M $2.06B
2022 Q4 228 86.1 M $2.18B
2022 Q3 225 86.9 M $1.68B
2022 Q2 218 86.2 M $2.20B
2022 Q1 210 81.1 M $2.09B
2021 Q4 214 78.1 M $3.25B
2021 Q3 178 74.5 M $3.24B
2021 Q2 170 76.9 M $3.64B
2021 Q1 166 75.7 M $3.87B
2020 Q4 148 78.9 M $2.11B
2020 Q3 120 70.1 M $2.41B
2020 Q2 113 53.5 M $2.19B
2020 Q1 63 37.9 M $1.30B
2019 Q4 39 36.6 M $460M